[Helicobacter pylori infection--current status in clinical practice and prospects].
Malfertheiner
P
P
Otto-von-Guericke Universität, Klinik für Gastroenterologie, Hepatologie und Infektiologie, Magdeburg.
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D019091:Critical Pathways; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005753:Gastric Mucosa / Q000473:pathology; D005756:Gastritis / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D016480:Helicobacter pylori; D006801:Humans; D010348:Patient Care Team; D012307:Risk Factors; D013276:Stomach Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents